Fluorescent Nerve-Targeting Peptides for Image-Guided Surgery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for identifying and preserving human nerves during surgical procedures are inadequate, as they lack visual guidance and can be unreliable, particularly in cases of trauma, tumor involvement, or infection, and often involve damaging fluorescent dyes.

Innovation Solution

The use of peptides that specifically bind to human nerves, such as SGQVPWEEPYYVVKKSS (HNP 401) and others, which can be conjugated with fluorescent moieties or drugs for targeted visualization and protection of nerves during surgery.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If EMG monitoring is used to identify nerves, then nerve identification can be achieved, but visual feedback is not provided to the surgeon

Engineering Contradiction:
Improvenerve identification accuracyVSAvoidvisual feedback
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The patent uses fluorescent dyes as intermediaries that bind to nerve tissues and emit fluorescence signals. This allows the nerve identification function (performed by EMG) to be visually transmitted to the surgeon through fluorescence imaging, bridging the information gap without requiring direct neural contact

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent replaces the electrical stimulation-based EMG monitoring system with an optical fluorescence imaging system. Instead of using electrical signals to detect and visualize nerves, the system uses fluorescent markers that emit light when excited, providing direct visual feedback to the surgeon

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Illumination intensity

If fluorescent dyes are injected to label nerves, then nerve visualization is improved, but the injection site becomes contaminated and may damage target organs

Engineering Contradiction:
Improvenerve visualizationVSAvoidmechanical damage and dye concentration toxicity
Core Design Contradiction:
Illumination intensityVSObject-affected harmful factors

Solution Approach 1:

The patent modifies the fluorescent dye molecules to have specific chemical properties that enable selective binding to nerve tissue components (such as neurofilaments or cell membranes). This localized binding ensures that fluorescence is concentrated at the nerve sites rather than distributed throughout the injection area, improving visualization while minimizing contamination and toxicity at the injection site

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent uses biodegradable fluorescent markers that temporarily label nerves during surgery and then naturally degrade or are eliminated from the body. This allows the use of fluorescent visualization without long-term persistence of potentially harmful dye concentrations at injection sites

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Measurement precision

If retrograde tracing is used to label nerves, then nerve identification is achieved, but the process takes a long time due to slow transport

Engineering Contradiction:
Improvenerve labeling accuracyVSAvoidlabeling time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent uses fluorescent markers that can directly bind to nerve structures at the injection site or along the nerve pathway without requiring transport through the nerve. This eliminates the time-consuming retrograde or anterograde transport process while maintaining accurate nerve labeling, as the markers immediately attach to nerve components upon administration

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Provides reliable visual feedback and effective nerve protection by specifically binding to human nerves, enhancing surgical precision and reducing nerve damage.

Implementation Method 1

peptides that specifically bind to human nerves

Methodology Applied
Scientific EffectMolecular binding:

Implementation Method 2

conjugated with fluorescent moieties or drugs for targeted visualization

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS12533425B2Methods and systems using peptides for targeting and mapping human nerves in image guided surgery, diagnostics and therapeutic delivery
Publication Date: 2026.01.27 ALUME BIOSCIENCES INC
  • US12533425B2 patent drawing
  • US12533425B2 patent drawing
  • US12533425B2 patent drawing

AI summary

The present invention provides methods for guiding preservation of human neurons or human nerves during surgery, as well as labeling and mapping nerves in targeted organs for map-guided surgery, by administering a fluorescently-labeled peptide that specifically binds to the human neurons or human nerves. The invention further provides human neuron or nerve targeting molecules comprising fluorescently-labeled peptides that specifically bind to human neurons or human nerves and compositions thereof.